News from sanofi A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

May 18, 2023, 11:55 ET Sanofi Applauds Supreme Court Ruling Supporting Scientific Innovation by Striking Down Amgen's Asserted PCSK9 Patent Claims in Amgen v Sanofi

Sanofi (NASDAQ: SNY) is pleased with the United States Supreme Court's ruling in Amgen v. Sanofi et. al. The decision unanimously affirms the United...

Apr 04, 2023, 10:34 ET Sanofi Breaks Ground on State-of-the-Art Facility in Swiftwater for Sustainable Production of Pandemic Flu Vaccines

Sanofi and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response...

Jan 18, 2023, 07:00 ET Sanofi launches first global scholarship program for students from underrepresented communities pursuing careers in healthcare

Sanofi announces at the 53rd Annual Meeting of the World Economic Forum in Davos the launch of the Sanofi NextGen Scholarship, its first global...

Dec 16, 2022, 08:30 ET Foundation S da Sanofi, seleciona projetos engajados na luta contra o câncer infantil

Dec 02, 2022, 14:00 ET Pacientes de ASMD, conhecida também como Doença de Niemann-Pick A, A/B ou B, celebram nova perspectiva de jornada com mais qualidade de vida

Oct 27, 2022, 11:09 ET Dia do Propósito na Sanofi engaja funcionários em ações com impacto nas regiões de São Paulo a Amazônia

Oct 06, 2022, 07:10 ET Sanofi US enters into co-promotion agreement with Provention Bio, Inc. to launch teplizumab, an investigational disease-modifying therapy for type 1 diabetes

Sanofi US has announced it has entered into a co-promotion service agreement with Provention Bio, Inc., for the commercialization of teplizumab in...

Aug 26, 2022, 08:00 ET Sanofi higher dose flu vaccines preferentially recommended for adults 65+ in CDC Morbidity and Mortality Weekly Report

The Centers for Disease Control and Prevention (CDC) has published the updated Advisory Committee on Immunization Practices (ACIP) guidance granting...

Aug 12, 2022, 11:00 ET Public health experts underscore importance of flu vaccinations to help reduce health inequities among high-risk populations

Vaccine fatigue may continue to be a barrier to the upcoming flu season Black Americans are less likely to get a flu vaccine compared to white...

Aug 03, 2022, 14:53 ET Sanofi appoints new Heads of U.S. General Medicines, and North America Vaccines and Consumer Healthcare

Sanofi announces three appointments to key leadership roles for U.S. General Medicines and its North American Vaccines and Consumer Healthcare...

Jul 26, 2022, 07:00 ET Sanofi partners with Howard University in an unprecedented pharmacy fellowship program

As part of its ongoing efforts to address disparities in underrepresented communities, Sanofi has announced a collaboration with Howard University...

Jul 01, 2022, 17:04 ET Sanofi flu vaccines licensed and approved for 2022-2023 influenza season, including CDC preferred higher-dose vaccines for adults 65+

* Fluzone® High-Dose Quadrivalent (Influenza Vaccine) and Flublok® Quadrivalent (Influenza Vaccine) are the only two flu vaccines proven to help...

Jun 07, 2022, 08:30 ET Sanofi unveils new 900,000-square-foot campus at Cambridge Crossing

Sanofi announces the opening of the company's new campus at Cambridge Crossing in Cambridge, Massachusetts. Governor Charlie Baker and Cambridge...

Nov 30, 2021, 09:05 ET Sanofi offers all employees worldwide 14 weeks paid parental leave to ensure workplace equality

In its continuing efforts to support gender equity in the workplace, Sanofi is offering all employees worldwide 14 weeks of paid parental leave...

Jun 28, 2021, 10:00 ET New Soliqua 100/33 data shows improved blood sugar control without weight gain versus premixed insulin

A new study of Soliqua® 100/33 (insulin glargine and lixisenatide injection) 100 Units/mL and 33 mcg/mL, iGlarLixi, met its two primary endpoints and ...

Jun 17, 2021, 07:02 ET Newly licensed US manufacturing facility to increase availability of Fluzone® High-Dose Quadrivalent (influenza vaccine)

The U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research has granted approval to Sanofi Pasteur, the vaccines global...

Jun 04, 2021, 01:00 ET Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer

Sanofi is partnering with leading groups delivering practice-changing breast cancer research, the Breast International Group (BIG), the European...

Jun 01, 2021, 06:45 ET Sanofi and Merck's first and only six-in-one pediatric combination vaccine now available in the United States

Vaxelis™ (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine), developed ...

May 19, 2021, 17:00 ET Early amcenestrant data featured at ASCO support its potential to become a new endocrine backbone therapy for ER+/HER2- breast cancer

Phase 1 data from the AMEERA-1 study evaluating amcenestrant, an investigational oral selective estrogen receptor degrader (SERD), will be presented...

May 06, 2021, 01:00 ET Sanofi establishes three-year collaboration with Stanford Medicine to accelerate immunology research

Sanofi has entered into a three-year research collaboration with Stanford University School of Medicine. Together, the two organizations and their...

Apr 26, 2021, 07:00 ET Sanofi to help manufacture Moderna COVID-19 vaccine, supporting global supply demands

Sanofi has entered into an agreement with Moderna, under which Sanofi will help manufacture Moderna´s COVID-19 vaccine, supporting the COVID-19...

Apr 07, 2021, 07:00 ET Sanofi expands its social commitments, creates nonprofit unit to provide poorest countries with access to essential medicines

In an open letter, Sanofi Chief Executive Officer Paul Hudson today outlined several key projects that the company will implement to increase the...

Mar 31, 2021, 18:13 ET FDA approves Sarclisa® (isatuximab-irfc) in combination with carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma

The U.S. Food and Drug Administration (FDA) has approved Sarclisa® (isatuximab-irfc) in combination with carfilzomib and dexamethasone (Kd), for the...